Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation

Chest

Volumn 132, Issue 5, 2007, Pages 1447-1454

  Ikegami, Machiko ^a,c   Scoville, Elizabeth A ^a   Grant, Shawn ^a   Korfhagen, Thomas ^a   Brondyk, William ^b   Scheule, Ronald K ^b   Whitsett, Jeffrey A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b GENZYME CORPORATION   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute lung injury; Cytokines; Pneumonia; Pulmonary surfactant; Sftpd mice

Indexed keywords

BERACTANT; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; SURFACTANT PROTEIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HOST RESISTANCE; INNATE IMMUNITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 36348995333     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0864     Document Type: Article

References (35)

1. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006; 21:119-143
2. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141:471-501
3. Weiland JE, Davis WB, Holter JF, et al. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am Rev Respir Dis 1986; 133:218-225
4. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19:177-201
5. Palaniyar N, Nadesalingam J, Reid KB. Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands. Immunobiology 2002; 205:575-594
6. van de Wetering JK, van Eijk M, van Golde LM, et al. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of Gram-positive bacteria. J Infect Dis 2001; 184:1143-1151
7. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol Lung Cell Mol Physiol 1998; 275:L1-L13
8. Korfhagen TR, Sheftelyevich V, Burhans MS, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998; 43:28438-28443
9. LeVine AM, Elliott J, Whitsett JA, et al. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 2004; 31:193-199
10. LeVine AM, Whitsett JA, Hartshorn KL, et al. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001; 167:5868-5873
11. Giannoni E, Sawa T, Allen L, et al. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 2006; 34:704-710
12. Miyamura K, Malhotra R, Hoppe HJ, et al. Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochim Biophys Acta 1994; 1210:303-307
13. Awasthi S, Coalson JJ, Crouch E, et al. Surfactant proteins A and D in premature baboons with chronic lung injury: evidence for an inhibition of secretion. Am J Respir Crit Care Med 1999; 160:942-949
14. Noah TL, Murphy PC, Alink JJ, et al. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 2003; 168:685-691
15. Epaud R, Ikegami M, Whitsett JA, et al. Surfactant protein B inhibits endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 2003; 28:373-378
16. Raychaudhuri B, Abraham S, Bonfield TL, et al. Surfactant blocks lipopolysaccharide signaling by inhibiting both mitogen-activated protein and IkappaB kinases in human alveolar macrophages. Am J Respir Cell Mol Biol 2004; 30:228-232
17. Jobe AH, Ueda T, Whitsett JA, et al. Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Ther 1996; 3:775-779
18. Whitsett JA, Hull WM, Ohning B, et al. Immunologic identification of a pulmonary surfactant-associated protein of molecular weight = 6000 daltons. Pediatr Res 1986; 20:744-749
19. Ikegami M, Carter K, Bishop K, et al. Intratracheal recombinant surfactant protein D prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 2006; 173:1342-1347
20. Ikegami M, Whitsett JA, Martis PC, et al. Reversibility of lung inflammation caused by SP-B deficiency. Am J Physiol Lung Cell Mol Physiol 2005; 289:L962-L970
21. Kramer BW, Jobe A, Ikegami M. Exogenous surfactant changes the phenotype of alveolar macrophages in mice. Am J Physiol Lung Cell Mol Physiol 2001; 280:L689-L694
22. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent J Biol Chem 193:265-275, 1951
23. Kuan SF, Rust K, Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides: surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest 1992; 90:97-106
24. Yao HW, Mao LG, Zhu JP. Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol 2006; 33:793-797
25. Leemans JC, Heikens M, van Kessel KP, et al. Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice. Clin Diagn Lab Immunol 2003; 10:950-953
26. Branger J, Florquin S, Knapp S, et al. LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia. Int Immunol 2004; 16:1605-1611
27. Crouch EC. Structure, biologic properties, and expression of surfactant protein D (SP-D). Biochim Biophys Acta 1998; 1408:278-289
28. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007; 131:913-920
29. Spragg RG, Lewis JF, Wurst W, et al. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 2003; 167:1562-1566
30. Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005; 293:470-476
31. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:1309-1315
32. Antal JM, Divis LT, Erzurum SC, et al. Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol 1996; 14:374-379
33. Togbe D, Schnyder-Candrian S, Schnyder B, et al. TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation. J Leukoc Biol 2006; 80:451-457
34. Wang XQ, Bdeir K, Yarovoi S, et al. Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. J Immunol 2006; 177:5550-5557
35. Ikegami M, Whitsett JA, Jobe AH, et al. Surfactant metabolism in SP-D gene ablated mice. Am J Physiol Lung Cell Mol Physiol 2000; 279:L468-L476